tirzepatide in mash EBM BLS: Leads to Resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Without Worsening of Fibrosis | Journal of General Internal Medicine 🔴 #SYNERGY_NASH Trial (NEJM, 2024)
Pay in 4 interest-free payments of $5.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2















.jpg)





